Physician profile
Allyson Edwards
NPI 1902253131
$767.61
in general payments reported to CMS, 2019-2025
13 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $152 · 2022: $58.24 · 2023: $16.98 · 2024: $216 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $391.52 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $104.63 | 2024-2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $58.24 | 2022 | |
| Pfizer INC. | $35.46 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $32.50 | 2021 | |
| Kestra Medical Technology Services, INC. | $26.17 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $26.10 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.56 | 2021 | |
| Solventum Corporation | $17.65 | 2025 | V.A.C. Granufoam, Prevena, V.A.C. Veraflo Cleanse Choice |
| Kci USA, INC. | $16.98 | 2023 | Prevena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.22 | 2021 | |
| Medtronic, INC. | $13.29 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.